Amphastar Pharmaceuticals (AMPH) Cash from Investing Activities (QoQ) (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) Cash from Investing Activities (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Amphastar Pharmaceuticals | 938.35 Mn | 648.22 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 368.15% |
| Mar 31, 2026 | 72.37% |
| Dec 31, 2025 | -208.73% |
| Sep 30, 2025 | -3,039.04% |
| Jun 30, 2025 | -105.96% |
| Mar 31, 2025 | 129.38% |
| Dec 31, 2024 | -3.16% |
| Sep 30, 2024 | 50.52% |
| Jun 30, 2024 | -558.77% |
| Mar 31, 2024 | 114.79% |
| Dec 31, 2023 | -230.79% |
| Sep 30, 2023 | 93.87% |
| Jun 30, 2023 | -7,930.66% |
| Mar 31, 2023 | -2,665.50% |
| Dec 31, 2022 | 98.50% |
| Sep 30, 2022 | -86.53% |
| Jun 30, 2022 | 10.21% |
| Mar 31, 2022 | 23.79% |
| Dec 31, 2021 | -217.17% |
| Sep 30, 2021 | 11.40% |